BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34234555)

  • 1. Prognostic Score Model Based on Ten Differentially Methylated Genes for Predicting Clinical Outcomes in Patients with Adenocarcinoma of the Colon.
    Sun G; Duan H; Xing Y; Zhang D
    Cancer Manag Res; 2021; 13():5113-5125. PubMed ID: 34234555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a Prognostic Model Based on Methylation-Related Genes in Patients with Colon Adenocarcinoma.
    Liu Z; Xu Y; Jin S; Liu X; Wang B
    Cancer Manag Res; 2023; 15():1097-1110. PubMed ID: 37818334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
    Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
    Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes.
    Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y
    J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
    Jin L; Li C; Liu T; Wang L
    Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients.
    Zhang C; Zhao Z; Liu H; Yao S; Zhao D
    Front Genet; 2021; 12():657658. PubMed ID: 34322151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Bioinformatics Analysis to Identify Abnormal Methylated Differentially Expressed Genes for Predicting Prognosis of Human Colon Cancer.
    Luo Y; Sun F; Peng X; Dong D; Ou W; Xie Y; Luo Y
    Int J Gen Med; 2021; 14():4745-4756. PubMed ID: 34466019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Analysis of DNA Methylation Identified 12 Signature Genes Specific to Metastatic ccRCC.
    Qian S; Sun S; Zhang L; Tian S; Xu K; Zhang G; Chen M
    Front Oncol; 2020; 10():556018. PubMed ID: 33134164
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic prediction of a 12-methylation gene-based risk score system on pancreatic adenocarcinoma.
    Dou D; Yang S; Zhang J
    Oncol Lett; 2020 Jul; 20(1):85-98. PubMed ID: 32565937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
    Zhou J; Wang X; Li Z; Jiang R
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
    Zhu Q; Tian G; Gao J
    Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
    Miao YD; Kou ZY; Wang JT; Mi DH
    World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics.
    Ke H; Wu Y; Wang R; Wu X
    Med Sci Monit; 2020 Oct; 26():e925833. PubMed ID: 33021972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma.
    Guo JN; Li MQ; Deng SH; Chen C; Ni Y; Cui BB; Liu YL
    Front Oncol; 2021; 11():640196. PubMed ID: 33763372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of Novel DNA Methylation-Based Prognostic Model to Predict Survival in Glioblastoma.
    Zhao J; Wang L; Kong D; Hu G; Wei B
    J Comput Biol; 2020 May; 27(5):718-728. PubMed ID: 31460783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation profiling analysis identifies a DNA methylation signature for predicting prognosis and recurrence of lung adenocarcinoma.
    Wang R; Zhu H; Yang M; Zhu C
    Oncol Lett; 2019 Dec; 18(6):5831-5842. PubMed ID: 31788056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
    Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
    Front Genet; 2022; 13():816173. PubMed ID: 35281843
    [No Abstract]   [Full Text] [Related]  

  • 20. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer.
    Bai G; Song J; Yuan Y; Chen Z; Tian Y; Yin X; Niu Y; Liu J
    J Cell Physiol; 2019 Dec; 234(12):22687-22702. PubMed ID: 31131446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.